BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34689042)

  • 1. De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis.
    Gaillard T; Carton M; Mailliez A; Desmoulins I; Mouret-Reynier MA; Petit T; Leheurteur M; Dieras V; Ferrero JM; Uwer L; Guiu S; Gonçalves A; Levy C; Debled M; Dalenc F; Patsouris A; Bachelot T; Eymard JC; Chevrot M; Conversano A; Robain M; Hequet D
    Eur J Cancer; 2021 Oct; 158():181-188. PubMed ID: 34689042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
    Lao C; Kuper-Hommel M; Elwood M; Campbell I; Edwards M; Lawrenson R
    Breast Cancer; 2021 Mar; 28(2):387-397. PubMed ID: 33044617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients.
    McKenzie HS; Maishman T; Simmonds P; Durcan L; ; Eccles D; Copson E
    Br J Cancer; 2020 May; 122(11):1618-1629. PubMed ID: 32231292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of De Novo Metastatic Breast Cancer.
    Daily K; Douglas E; Romitti PA; Thomas A
    Clin Breast Cancer; 2021 Aug; 21(4):302-308. PubMed ID: 33750642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicomolecular landscape of de novo versus relapsed stage IV metastatic breast cancer.
    Seltzer S; Corrigan M; O'Reilly S
    Exp Mol Pathol; 2020 Jun; 114():104404. PubMed ID: 32067942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
    Malmgren JA; Mayer M; Atwood MK; Kaplan HG
    Breast Cancer Res Treat; 2018 Jan; 167(2):579-590. PubMed ID: 29039120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Characterization of
    Garrido-Castro AC; Spurr LF; Hughes ME; Li YY; Cherniack AD; Kumari P; Lloyd MR; Bychkovsky B; Barroso-Sousa R; Di Lascio S; Jain E; Files J; Mohammed-Abreu A; Krevalin M; MacKichan C; Barry WT; Guo H; Xia D; Cerami E; Rollins BJ; MacConaill LE; Lindeman NI; Krop IE; Johnson BE; Wagle N; Winer EP; Dillon DA; Lin NU
    Clin Cancer Res; 2021 Feb; 27(4):1105-1118. PubMed ID: 33293374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry.
    Müller V; Hein A; Hartkopf AD; Fasching PA; Kolberg HC; Hadji P; Tesch H; Häberle L; Ettl J; Lüftner D; Wallwiener M; Beckmann MW; Schneeweiss A; Belleville E; Uhrig S; Wimberger P; Hielscher C; Meyer J; Wurmthaler LA; Kurbacher CM; Wuerstlein R; Untch M; Janni W; Taran FA; Lux MP; Wallwiener D; Brucker SY; Fehm TN; Michel LL
    Eur J Cancer; 2022 Sep; 172():13-21. PubMed ID: 35728342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Primary Surgery in
    Demirors B; Goktepe B; Medeck H; Ozbas S; Soran A
    Eur J Breast Health; 2023 Apr; 19(2):110-114. PubMed ID: 37025581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HR
    Torrisi R; Jacobs F; Miggiano C; De Sanctis R; Santoro A
    Drugs Context; 2023; 12():. PubMed ID: 36926051
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang L; Li Z; Zhang J; Wu Y; Zhu Y; Tong Z
    Oncol Lett; 2020 Apr; 19(4):2884-2894. PubMed ID: 32218843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer.
    Plichta JK; Thomas SM; Hayes DF; Chavez-MacGregor M; Allison K; de Los Santos J; Fowler AM; Giuliano AE; Sharma P; Smith BD; van Eycken E; Edge SB; Hortobagyi GN
    J Clin Oncol; 2023 May; 41(14):2546-2560. PubMed ID: 36944149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
    Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Rivera S; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; De La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Courtinard C; Filleron T; Robain M; Dalenc F
    Radiother Oncol; 2020 Apr; 145():109-116. PubMed ID: 31931289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional Therapy in De novo Metastatic Breast Cancer: A Retrospective Cohort Study.
    Jianna S; Lingjun K; Nana F; Hong L; Chongxi R
    Technol Cancer Res Treat; 2022; 21():15330338221115356. PubMed ID: 35899318
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival among patients with untreated metastatic breast cancer: "What if I do nothing?".
    Plichta JK; Thomas SM; Wang X; McDuff SGR; Kimmick G; Hwang ES
    Breast Cancer Res Treat; 2024 Jun; 205(2):333-347. PubMed ID: 38438700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer.
    Berg T; Jensen MB; Rossing M; Bechmann T; Donskov F; Knoop AS; Ejlertsen B
    JAMA Netw Open; 2024 Mar; 7(3):e242174. PubMed ID: 38477916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive local therapy for
    Liu B; Liu H; Liu M
    Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37449542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
    Hotton J; Lusque A; Leufflen L; Campone M; Levy C; Honart JF; Mailliez A; Debled M; Gutowski M; Leheurteur M; Goncalves A; Jankowski C; Guillermet S; Bachelot T; Ferrero JM; Eymard JC; Petit T; Pouget N; de La Lande B; Frenel JS; Villacroux O; Simon G; Pons-Tostivint E; Marchai F
    Ann Surg; 2023 Jan; 277(1):e153-e161. PubMed ID: 33534229
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lord SJ; Bahlmann K; O'Connell DL; Kiely BE; Daniels B; Pearson SA; Beith J; Bulsara MK; Houssami N
    EClinicalMedicine; 2022 Feb; 44():101282. PubMed ID: 35128368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?
    Rosier L; Wang Y; Lee JH; Daily K
    Breast Cancer Res Treat; 2022 Jan; 191(2):375-383. PubMed ID: 34787760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.